Skin And Skin Structure Infections (SSSI) Caused By Bacteria - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Skin And Skin Structure Infections (SSSI) Caused By Bacteria - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" drug pipelines to their offering.

Skin And Skin Structure Infections Caused By Bacteria - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe.

A key objective of the Skin And Skin Structure Infections Caused By Bacteria Report is to understand the market and pipeline status of the drugs around the Skin And Skin Structure Infections Caused By Bacteria to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline strategies. The Report provides the historical and forecasted sales of the drugs till 2018.

The Skin And Skin Structure Infections Caused By Bacteria Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Skin And Skin Structure Infections Caused By Bacteria.

While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Key Topics Covered:

1. Indication Overview

2. Market Drugs Landscape

3. Global API Manufacturers Assessment

4. Phase III Drugs Landscape

5. Drugs Market Data and Forecasted Sales Figure-2018

6. Marketed Drugs for Skin And Skin Structure Infections Caused By Bacteria

7. Phase III Drugs for Skin And Skin Structure Infections Caused By Bacteria

8. Discontinued Drugs for Skin And Skin Structure Infections Caused By Bacteria

9. Appendix

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/frvbg4/skin_and_skin

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Diseases Drugs, Dermatological Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Diseases Drugs, Dermatological Drugs